Literature DB >> 12727957

Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.

Antongiulio Faggiano1, Rosario Pivonello, Daniela Melis, Mariagiovanna Filippella, Carolina Di Somma, Mario Petretta, Gaetano Lombardi, Annamaria Colao.   

Abstract

The pathogenesis of nephrolithiasis in Cushing's syndrome is still not completely clarified. The current study aimed at investigating prevalence of nephrolithiasis and role of different lithogenic factors in Cushing's disease (CD). Forty-six CD patients (24 with active and 22 with cured disease) and 46 sex- and age-matched controls entered the study. Body mass index, blood pressure, fasting glucose and insulin, serum and urinary creatinine, urea, uric acid, electrolytes, and cystine, urinary volume, pH, oxalate, and citrate levels, and renal ultrasonography (US) were performed in all patients and controls. Nephrolithiasis was found in 50% of active patients, 27.3% of cured patients, and 6.5% of controls (P < 0.001). Compared with controls, patients with active disease had a significantly increased prevalence of obesity, arterial hypertension, diabetes mellitus, hypercalciuria, hypocitraturia, and hyperuricosuria, significantly higher levels of serum and urinary cystine, urinary creatinine, urea, uric acid, potassium, calcium, phosphorus, and oxalate, significantly lower levels of urinary citrate levels. Compared with controls, patients cured from CD had a significantly increased prevalence of obesity, systemic arterial hypertension, and diabetes mellitus, whereas urinary citrate was significantly decreased. At multivariate analysis, a significantly increased risk to develop kidney stones was independently associated with urinary excretion of uric acid (odds ratio = 1.6, confidence interval = 1.0-2.5) and systemic arterial blood pressure (odds ratio = 2.6, confidence interval = 1.1-6.6). In conclusion, patients with active CD have an increased prevalence of nephrolithiasis compared with general population, which decreases but not disappears in patients successfully cured from the disease. This complication is likely caused by the synergic effect of different hypercortisolism-dependent metabolic and hemodynamic abnormalities, among which systemic arterial hypertension and excessive urinary uric acid excretion seem to play a pivotal role.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727957     DOI: 10.1210/jc.2002-021494

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

Review 1.  Managing Cushing's disease: the state of the art.

Authors:  Annamaria Colao; Marco Boscaro; Diego Ferone; Felipe F Casanueva
Journal:  Endocrine       Date:  2014-01-11       Impact factor: 3.633

Review 2.  Pathogenesis of calcium oxalate urinary stone disease: species comparison of humans, dogs, and cats.

Authors:  Allison L O'Kell; David C Grant; Saeed R Khan
Journal:  Urolithiasis       Date:  2017-03-30       Impact factor: 3.436

Review 3.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

Review 4.  Clinical consequences of Cushing's syndrome.

Authors:  Elena Valassi; Iris Crespo; Alicia Santos; Susan M Webb
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

Review 5.  Cushing's disease.

Authors:  Martina De Martin; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

6.  Trends in pediatric urolithiasis: patient characteristics, associated diagnoses, and financial burden.

Authors:  Kirsten Kusumi; Brian Becknell; Andrew Schwaderer
Journal:  Pediatr Nephrol       Date:  2014-12-07       Impact factor: 3.714

7.  Kidney stones: a fetal origins hypothesis.

Authors:  Sarah A Howles; Mark H Edwards; Cyrus Cooper; Rajesh V Thakker
Journal:  J Bone Miner Res       Date:  2013-12       Impact factor: 6.741

8.  Kidney Stones as an Underrecognized Clinical Sign in Pediatric Cushing Disease.

Authors:  Sara H Rahman; Georgios Z Papadakis; Margaret F Keil; Fabio R Faucz; Maya B Lodish; Constantine A Stratakis
Journal:  J Pediatr       Date:  2015-12-15       Impact factor: 4.406

9.  Management of renal transplant urolithiasis: a multicentre study by the French Urology Association Transplantation Committee.

Authors:  J Branchereau; M O Timsit; Y Neuzillet; T Bessède; R Thuret; M Gigante; X Tillou; R Codas; J Boutin; A Doerfler; F Sallusto; T Culty; V Delaporte; N Brichart; B Barrou; L Salomon; G Karam; J Rigaud; L Badet; F Kleinklauss
Journal:  World J Urol       Date:  2017-10-22       Impact factor: 4.226

Review 10.  Quality of life and other outcomes in children treated for Cushing syndrome.

Authors:  Margaret F Keil
Journal:  J Clin Endocrinol Metab       Date:  2013-05-02       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.